logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
F

Franck Morschhauser

Department of Hematology

92H指数
926论文数
3.4W被引数
收录论文 163
发表时间
logo
Response kinetics following CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry大B细胞淋巴瘤CAR T细胞疗法后的应答动力学：DESCAR-T登记研究中的LYSA研究
errBone Marrow Transplantation
IF5.2
err2026-08-21
err0
PREAI
errGuillaume Manson; Roberta Di Blasi; Roch Houot; Franck Morschhauser; Guillaume Cartron; Thomas Gastinne; Didier Blaise; François-Xavier Gros; Pierre Bories; Fabien Le Bras; Marie-Thérèse Rubio; Mohammad Mohty; Jacques-Olivier Bay; Stéphanie Guidez; Cristina Castilla Llorente; Fabrice Jardin; Amandine Durand; Blandine Guffroy; Michaël Loschi; Laurianne Drieu La Rochelle; Julie Abraham; Adrien Chauchet; Laura Herbreteau; Sylvain Choquet; Magalie Joris; Sylvain Carras; Gandhi-Laurent Damaj; Justine Decroocq; Tanguy-Schmidt Aline; Olivier Hermine; Emmanuelle Nicolas-Virelizier; Elodie Gat; Steven Le Gouill; Emmanuel Bachy; Remy Dulery
err分享
err收藏
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trialEnglumafusp alfa联合glofitamab治疗b  细胞非霍奇金淋巴瘤: 1期试验
errNature Medicine
IF50
err2026-07-16
err0
errOAAI
errMartin Hutchings; Michael Dickinson; Giuseppe Gritti; Carmelo Carlo-Stella; William Townsend; Francesc Bosch; Nancy L. Bartlett; Guillaume Cartron; Herve Ghesquieres; Roch Houot; Harriet Walter; Fritz Offner; Natalie Dimier; Candice Jamois; Sylvia Herter; Abiraj Keelara; Sabine Wilson; Jeremy Gallien; Heather Hinton; Isabel Prieto Gonzalez-Albo; Koorosh Korfi; Georgios Kazantzidis; Marie-Hélène Wasmer; Katharina Lechner; Franck Morschhauser
err分享
err收藏
Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA study原发纵隔大B细胞淋巴瘤中循环肿瘤DNA的 interim assessment：一项多中心LYSA研究
errBlood Advances
IF7.1
err2026-04-16
err0
errOAAI
errVincent Camus; Daphné Krzisch; Alessio Bruscaggin; Emilie Lévêque; Mathieu Viennot; Luc-Matthieu Fornecker; Morgane Cheminant; Sébastien Bailly; Franck Morschhauser; Pierre Feugier; Sylvain Choquet; Eric Durot; Sylvain Carras; Caroline Delette; Gandhi-Laurent Damaj; Agathe Waultier-Rascalou; Pierre Lebreton; Katell Le Du; Jean Galtier; Roch Houot
err分享
err收藏
Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trial固定疗程维奈克拉 vs FCR/BR 在初治慢性淋巴细胞白血病患者中的疗效：CRISTALLO III期试验主要分析
errBlood
IF23.1
err2026-03-04
err0
errOAAI
errJeff P. Sharman; Luca Laurenti; Emmanuelle Ferrant; Luis Felipe Casado Montero; Stephen P. Mulligan; Rosemary Harrup; Stephen Opat; Adalberto Ibatici; Roberto Marasca; Paolo Sportoletti; Maria Thadani-Mulero; Oscar Cazares; Weize Huang; Yanwen Jiang; Emma Clark; Hyun Yong Jin; Michelle Boyer; Franck Morschhauser
err分享
err收藏
Outcomes and treatment patterns of patients with primary mediastinal B-cell lymphoma after CAR-T cell therapy failure: A DESCAR-T analysis原发性纵隔B细胞淋巴瘤患者在CAR-T细胞疗法失败后的结局与治疗模式：一项DESCAR-T分析
errHEMASPHERE
IF14.6
err2025-12-01
err0
errOAAI
errGaltier, Jean; Sesques, Pierre; Dupont, Vivien; Bachy, Emmanuel; Di Blasi, Roberta; Thieblemont, Catherine; Brisou, Gabriel; Gastinne, Thomas; Cartron, Guillaume; Gros, Francois-xavier; Morschhauser, Franck; Andre, Axel; Bay, Jacques-olivier; Joris, Magalie; Tanguy-schmidt, Aline; Demailly, Audrey; Le Gouill, Steven; Houot, Roch; Bouabdallah, Krimo; Camus, Vincent
err分享
err收藏
Early Positron Emission Tomography Response-Adapted Treatment in Low-Risk Diffuse Large B-Cell lymphoma: an open label, multicenter, randomised, non-inferiority phase 3 trial.早期正电子发射断层扫描反应适应性治疗在低风险弥漫性大B细胞淋巴瘤中的应用：一项开放标签、多中心、随机、非劣效性III期临床试验。
errAnnals of Oncology
IF65.4
err2025-11-17
err0
PREAI
errJean-Marie Michot; Serge Bologna; Jean-Noël Bastie; Thierry Vander Borght; Josette Brière; Vincent Ribrag; Come Bommier; Frédéric Peyrade; Laure Lebras; Gandhi Damaj; Diane Coso; David Sibon; Christophe Bonnet; Franck Morschhauser; Hervé Ghesquières; Christophe Fruchart; Carole Soussain; Stéphanie Becker; Pierre Olivier; Anne Julian
err分享
err收藏
Late failure of aggressive B-cell lymphoma following CAR T-cell therapy: a LYSA study from the DESCAR-T registryCAR T细胞疗法后侵袭性B细胞淋巴瘤的晚期复发：一项来自DESCAR-T登记研究的LYSA研究
errBlood Advances
IF7.1
err2025-10-24
err0
errOAAI
errFederico Erbella; Emmanuel Bachy; Guillaume Cartron; Elodie Gat; Guillaume Manson; Franck Morschhauser; Francois-Xavier Gros; Louise Roulin; Benoit Tessoulin; Pierre Bories; Olivier Tournilhac; Laure Ricard; Stéphanie Guidez; Sylvain Choquet; Rene-Olivier Casasnovas; Gabriel Brisou; Arnaud Campidelli; Cristina Castilla-Llorente; Fabrice Jardin; Emmanuel Gyan; Blandine Guffroy; Julie Abraham; Justine Decroocq; Adrien Chauchet; Magalie Joris; Fabien Claves; Sylvain Carras; Gaëlle Guillerm; Michaël Loschi; Olivier Hermine; Aline Taguy-Schimidt; Steven Le Gouill; Roch Houot; Roberta Di Blasi
err分享
err收藏
Invasive Fungal Infections after CD19 CAR T-cell Therapy for B-Cell Lymphoma: a LYSA study from the DESCAR-T RegistryCD19 CAR T细胞疗法治疗B细胞淋巴瘤后的侵袭性真菌感染：一项来自DESCAR-T登记研究的LYSA研究
errClinical Microbiology and Infection
IF8.5
err2025-10-16
err0
errOAAI
errAmélie Bouvier; Amandine Durand; Vivien Dupont; Nicolas Gower; Cristina Castilla Lorente; Arnaud Campidelli; Rémi Dulery; Jean-Pierre Gangneux; Magalie Joris; Martin Eloit; Christelle Latiere; Roberta di Blasi; Blandine Denis; Ludovic Gabellier; Franck Morschhauser; Olivier Casasnovas; Roch Houot; Cécile Angebault; Emmanuel Bachy; Fabien Le Bras; Thomas Gastinne; Jean-Jacques Tudesq; François Lemonnier; Giovanna Melica
err分享
err收藏
Risk stratification of diffuse large B-cell lymphoma patients using plasma NMR-based metabolomics at diagnostic使用血浆NMR基代谢组学对弥漫性大B细胞淋巴瘤患者进行风险分层以用于诊断
errBlood Advances
IF7.1
err2025-10-10
err0
errOAAI
errAurélie Montagne; Gildas Bertho; Thomas Papastergiou; Loïc Chartier; Romain Ricci; Fabrice Jardin; Hervé Ghesquières; Cédric Rossi; Franck Morschhauser; Corinne Haioun; Vincent Ribrag; Pierre Feugier; Gabriel Brisou; Lucie Oberic; Philippe Gaulard; Nicolas Giraud; Younès Bennani; Catherine Thieblemont; Véronique Baud
err分享
err收藏
B CAR T-CELL THERAPY IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS: A MULTICENTER RETROSPECTIVE STUDY FROM THE LOC NETWORKB CAR T细胞疗法在原发性中枢神经系统淋巴瘤中的应用：LOC网络的多中心回顾性研究
errNEURO-ONCOLOGY
IF13.4
err2025-10-01
err0
errOAAI
errBouille, F.; Baron, M.; Houot, R.; Ursu, R.; Boussen, I; Soussain, C.; Waultier-Rascalou, A.; Guffroy, B.; Ahle, G.; Blonski, M.; Morschhauser, F.; Willems, L.; Gastinne, T.; Jerome, P.; Molucon-Chabrot, C.; Schmitt, A.; Schenone, L.; Corvilain, E.; Gyan, E.; Jardin, F.; Morel, V; Barrie, M.; Laribi, K.; Alcantara, M.; Campidelli, A.; Herbaux, C.; Hoang-Xuan, K.; Choquet, S.; Houillier, C.
err分享
err收藏
PROs versus clinician-reported adverse events in a large clinical trial: findings from the Phase 3 POLARIX study患者报告结果(PROs)与临床医生报告的不良事件在大型临床试验中的比较：来自III期POLARIX研究的结果
errBlood
IF23.1
err2025-09-29
err0
errOAAI
errCarrie Thompson; Marek Trněný; Franck Morschhauser; Gilles Salles; Patrick M. Reagan; Mark Hertzberg; Huilai Zhang; Catherine Thieblemont; Bei Hu; Gustavo Fonseca; Won Seog Kim; Maurizio Martelli; Amitkumar Mehta; Avrita Singh; Mark Yan; Jamie Hirata; Matthew Sugidono; Calvin Lee; Jeff P. Sharman; Neha Mehta-Shah; Christopher R. Flowers; Hervé Tilly; Neil Chua; René-Olivier Casasnovas; Fiona Miall; Tae Min Kim; Xavier Cheng-Hong Tsai; Sunita Nasta; Seung Tae Lee; Jonathan W. Friedberg
err分享
err收藏
89Zr-mAb uptake interpretation requires the use of tissue to plasma ratios corrected for antibody catabolism89Zr-mAb的摄取解释需要使用校正了抗体分解代谢的组织与血浆比率。
errEJNMMI Research
IF3
err2025-09-26
err0
errOAAI
errMarc C. Huisman; Johanna E. E. Pouw; Sandeep S. V. Golla; Damien Huglo; Franck Morschhauser; Josée M. Zijlstra; Jessica E. Wijngaarden; Mirte Stavenga; Hylke J. Sebus; Maarten Slebe; Andrea Thiele; Danielle Vugts; Iris H. C. Miedema; Gerben J.C. Zwezerijnen; Idris Bahce; C. Willemien Menke-van der Houven van Oordt; Dhaval K. Shah; Yvonne W. S. Jauw; Ronald Boellaard
err分享
err收藏
Association of PET4 Response With Outcomes of BV-CHP vs CHOP in the ECHELON-2 Trial in CD30+ Peripheral T-cell LymphomaPET4反应与ECHELON-2试验中CD30+外周T细胞淋巴瘤患者接受BV-CHP vs CHOP治疗的结局相关性研究
errBlood Advances
IF7.1
err2025-08-21
err0
errOAAI
errSwaminathan Iyer; Neha Mehta-Shah; Ranjana Advani; Nancy L. Bartlett; Jacob H. Christensen; Franck Morschhauser; Eva Domingo-Domenech; Giuseppe Rossi; Won Seog Kim; Onder Alpdogan; Tatyana A. Feldman; Vincent Camus; Giuseppe Gritti; Pier Luigi Zinzani; David Belada; Jiri Mayer; Ilseung Choi; June-Won Cheong; Evelyn Rustia; Keenan Fenton
err分享
err收藏
Brentuximab Vedotin addition to Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphoma: a LYSA Phase II StudyBrentuximab Vedotin联合Gemcitabine治疗复发或难治性外周T细胞淋巴瘤：一项LYSA II期研究
errBlood Advances
IF7.1
err2025-08-06
err0
errOAAI
errOlivier Tournilhac; Kamal Bouabdallah; Solene Lecolant; Maya Hacini; Kamel Laribi; Sébastien Bailly; Thibaut Belmondo; Marie Maerevoet; Loic Ysebaert; Stephanie Guidez; Steven Le Gouill; Christophe Bonnet; Marc André; Jehan Dupuis; Catherine Thieblemont; Emmanuel Bachy; Nicolas Daguindau; Franck Morschhauser; Sabine Tricot; Charline Moulin; Anne Banos; Roch Houot; Adrien Chauchet; Emmanuel Gyan; Guillaume Cartron; Hassan Farhat; Vincent Camus; Bernard Drenou; Hacene Zerazhi; David Sibon; Emmanuelle Nicolas-Virelizier; Caroline Delette; Sylvia Snauwaert; Sarah Bailly; Richard Delarue; Sylvain Carras; Albane Ledoux-Pilon; Marie Parrens; Samuel Griolet; Philippe Gaulard; Marie-Helene Delfau-Larue; Laurence de Leval; Gandhi Laurent Damaj
err分享
err收藏
Lymphoma B cells remodel bone marrow stromal cells into extracellular matrix–producing cancer-associated fibroblasts淋巴瘤B细胞将骨髓基质细胞重塑为产生细胞外基质的肿瘤相关成纤维细胞
errBlood Advances
IF7.1
err2025-05-05
err0
errOAAI
errElise Dessauge; Baptiste Brauge; Simon Léonard; Alicia Beyou; Camille Laurent; Valentin Isen; Nicolas Barbier; Céline Monvoisin; Thomas Lejeune; Jérôme Destin; Florence Jouan; Judikael Saout; Francisco Llamas-Gutierrez; Franck Morschhauser; Sandrine Roulland; David Roulois; Frédéric Mourcin; Karin Tarte
err分享
err收藏
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA studyGlofitamab在难治性或复发性弥漫性大B细胞淋巴瘤中的应用：一项在CAR-T细胞疗法失败后的II期LYSA研究
errNATURE CANCER
IF28.5
err2025-04-03
err0
PREAI
errCartron, Guillaume; Houot, Roch; Al Tabaa, Yassine; Le Bras, Fabien; Ysebaert, Loic; Choquet, Sylvain; Jardin, Fabrice; Bay, Jacques-Olivier; Gros, Francois-Xavier; Morschhauser, Franck; Casasnovas, Olivier; Gastinne, Thomas; Thieblemont, Catherine; Joris, Magalie; Ricard, Laure; Regny, Caroline; La Rochelle, Laurianne Drieu; Feugier, Pierre; Marcais, Ambroise; Griolet, Samuel; Laurent, Camille; Sesques, Pierre
err分享
err收藏
Efficacy of tazemetostat in combination with R-CHOP in elderly patients newly diagnosed with diffuse large B cell lymphoma: results of the EpiRCHOP phase II study of the LYSA塔泽莫斯托stat与R-CHOP联合治疗新诊断弥漫性大B细胞淋巴瘤老年患者的疗效：LYSA的EpiRCHOP II期研究结果
errECLINICALMEDICINE
IF10
err2025-04-01
err0
PREAI
errSarkozy, Clementine; Molina, Thierry Jo; Dubois, Sydney; Portugues, Cedric; Bohers, Elodie; Ysebaert, Loic; Houot, Roch; Pica, Gian Matteo; Ruminy, Philippe; Herbaux, Charles; Gastinne, Thomas; Thieblemont, Catherine; Haioun, Corinne; Guidez, Stephanie; Bonnet, Christophe; Crochet, Gilles; Veresezan, Liana; Choquet, Sylvain; Bachy, Emmanuel; Jardin, Fabrice; Morschhauser, Franck; Ribrag, Vincent
err分享
err收藏
Is there a relationship between tumour aggressiveness and ovarian stimulation outcomes in adolescent and young adult patients with lymphoma?
errREPRODUCTIVE BIOMEDICINE ONLINE
IF3.5
err2025-03-01
err0
errOAAI
errSimon, V.; Chuzel, C.; Behal, H.; Labreuche, J.; Manier, S.; Morschhauser, F.; Pigny, P.; Keller, L.; Nudel, M.; Decanter, C.
err分享
err收藏
Safety and Efficacy of Tinostamustine in a Subpopulation of Patients With Relapsed/Refractory Hodgkin Lymphoma From a Phase I Trial
errHEMATOLOGICAL ONCOLOGY
IF3.9
err2024-12-01
err0
PREAI
errSureda, Anna; Pinto, Antonio; Ghesquieres, Herve; Morschhauser, Franck; Tournilhac, Olivier; Mutsaers, Pim; Zijlstra, Josee M.; De Filippi, Rosaria; Hilgier, Kasia; Manamley, Nick; Janik, Tomas; Zinzani, Pier Luigi
err分享
err收藏
Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab inpatients with relapsed/refractory large B-cell lymphoma地塞米松与 glofitamab 预治疗中替代糖皮质激素方案相比，可降低大B细胞淋巴瘤复发/难治性患者细胞因子释放综合征的发生频率和强度。
errHAEMATOLOGICA
IF7.9
err2024-11-28
err0
errOAAI
errFalchi, Lorenzo; Hutchings, Martin; Carlo-Stella, Carmelo; Morschhauser, Franck; Dickinson, Michael; Cartron, Guillaume; Khan, Cyrus; Tani, Monica; Martinez-Lopez, Joaquin; Bartlett, Nancy L.; Salar, Antonio; Brody, Joshua D.; Berthier, Aurelien; Kallemeijn, Martine; Relf, James; Tchaleu, Fabiola Bene; Lundberg, Linda; Bachy, Emmanuel
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
G
Gad Getz
H 指数: 248 · 论文数: 1.8K
D
David Cunningham
H 指数: 153 · 论文数: 2.1K
R
Randy D. Gascoyne
H 指数: 152 · 论文数: 1.0K
O
Olivier Hermine
H 指数: 135 · 论文数: 1.8K
S
Sylvie Chevret
H 指数: 129 · 论文数: 1.1K
查看更多